See also this year's filing and all EDGAR filings for this company.
PDF Report 0001479290_2024_Revance_Therapeutics_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001479290, Revance Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 338,865,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 9,808,000 |
| 2 | PropertyPlantAndEquipmentNet | 17,225,000 |
| 3 | remainder_Assets | 112,556,000 |
| 4 | LiabilitiesCurrent | 89,224,000 |
| 5 | LiabilitiesNoncurrent | 540,834,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 450,069,145 |
| 9 | ResearchAndDevelopmentExpense | 60,075,828 |
| 10 | remainder_Expenses | 208,161,590 |
| 11 | remainder_Revenues | 740,975,656 |
| 12 | remainder_NetIncome | 21,774,248 |
| 13 | remainder_ComprehensiveNetIncome | -355,279 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 478,454,000 |
| 1 | Liabilities | 630,058,000 |
| 2 | Expenses | 718,306,563 |
| 3 | Revenues | 740,975,656 |
| 4 | StockholdersEquity | -151,604,000 |
| 5 | NetIncome | 44,443,341 |
| 6 | ComprehensiveNetIncome | 44,265,702 |
| 7 | BaseVar | 1,294,961,873 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -0.516 |
| 9 | EconomicCapitalRatio | 1.38 |
Edgar->Model Mapping
Feature Distribution
Change over Time
